{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:05:34Z","timestamp":1746245134744,"version":"3.40.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"DOI":"10.7759\/cureus.83340","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:57:49Z","timestamp":1746187069000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunotherapy-Based Combination Therapy for the Successful Treatment of Coexisting Primary and Axillary Accessory Breast Cancers: A Case Report"],"prefix":"10.7759","author":[{"given":"Yuko","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_69_24","article-title":"Accessory breast tissue-A matter for exigence!","volume":"13","author":"Tomey VS","year":"2024","unstructured":"Tomey VS, Shivsharan PS, Kalbande SS, Joshi MS. Accessory breast tissue-A matter for exigence!. J Family Med Prim Care. 2024, 13:3926-30. 10.4103\/jfmpc.jfmpc_69_24","journal-title":"J Family Med Prim Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2020.05.038","article-title":"Axillary accessory breast cancer with persistent left superior vena cava: a case report and treatment controversy","volume":"73","author":"Zhang J","year":"2020","unstructured":"Zhang J, Zhang W, Min M, Pan Y. Axillary accessory breast cancer with persistent left superior vena cava: a case report and treatment controversy. Int J Surg Case Rep. 2020, 73:71-4. 10.1016\/j.ijscr.2020.05.038","journal-title":"Int J Surg Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2017.08.008","article-title":"Inflammatory breast cancer in accessory abdominal breast tissue","volume":"12","author":"Miles RC","year":"2017","unstructured":"Miles RC, Amornsiripanitch N, Scheel J. Inflammatory breast cancer in accessory abdominal breast tissue. Radiol Case Rep. 2017, 12:639-41. 10.1016\/j.radcr.2017.08.008","journal-title":"Radiol Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/286210","article-title":"Male breast cancer originating in an accessory mammary gland in the axilla: a case report","volume":"2012","author":"Yamamura J","year":"2012","unstructured":"Yamamura J, Masuda N, Kodama Y, et al.. Male breast cancer originating in an accessory mammary gland in the axilla: a case report. Case Rep Med. 2012, 2012:286210. 10.1155\/2012\/286210","journal-title":"Case Rep Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-33","article-title":"Male triple negative axillary accessory breast cancer-a case report","volume":"11","author":"Li C","year":"2022","unstructured":"Li C, Qian B. Male triple negative axillary accessory breast cancer-a case report. Transl Cancer Res. 2022, 11:2926-30. 10.21037\/tcr-22-33","journal-title":"Transl Cancer Res"},{"key":"ref6","article-title":"Diagnosis and treatment of accessory breast cancer in 11 patients","volume":"10","author":"Zhang S","year":"2015","unstructured":"Zhang S, Yu YH, Qu W, Zhang Y, Li J. Diagnosis and treatment of accessory breast cancer in 11 patients. Oncol Lett. 2015, 10:1783-8.","journal-title":"Oncol Lett"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-022-01619-2","article-title":"Invasive cancer in accessory axillary breast: a rare presentation","volume":"14","author":"Rateria N","year":"2023","unstructured":"Rateria N, Naidu PG, Tewari M. Invasive cancer in accessory axillary breast: a rare presentation. Indian J Surg Oncol. 2023, 14:40-1. 10.1007\/s13193-022-01619-2","journal-title":"Indian J Surg Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-021-01285-6","article-title":"Accessory breast cancer in the inframammary region: a case report and review of the literature","volume":"7","author":"Eguchi Y","year":"2021","unstructured":"Eguchi Y, Yoshinaka H, Hayashi N, et al.. Accessory breast cancer in the inframammary region: a case report and review of the literature. Surg Case Rep. 2021, 7:203. 10.1186\/s40792-021-01285-6","journal-title":"Surg Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4274\/ejbh.galenos.2021.2021-7-3","article-title":"Axillary reverse lymphatic mapping in the treatment of axillary accessory breast cancer: a case report and review of management","volume":"18","author":"Friedman-Eldar O","year":"2022","unstructured":"Friedman-Eldar O, Melnikau S, Tjendra Y, Avisar E. Axillary reverse lymphatic mapping in the treatment of axillary accessory breast cancer: a case report and review of management. Eur J Breast Health. 2022, 18:1-5. 10.4274\/ejbh.galenos.2021.2021-7-3","journal-title":"Eur J Breast Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/15579883231171010","article-title":"Male accessory breast cancer successfully treated with single-agent trastuzumab: a case report","volume":"17","author":"Ji W","year":"2023","unstructured":"Ji W, Guo W. Male accessory breast cancer successfully treated with single-agent trastuzumab: a case report. Am J Mens Health. 2023, 17:15579883231171010. 10.1177\/15579883231171010","journal-title":"Am J Mens Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033672","article-title":"Axillary accessory breast cancer reconstructed by a thoracodorsal artery perforator flap: a case report","volume":"102","author":"Yumoto A","year":"2023","unstructured":"Yumoto A, Otsuki Y, Nuri T, Higashino E, Kimura K, Iwamoto M, Ueda K. Axillary accessory breast cancer reconstructed by a thoracodorsal artery perforator flap: a case report. Medicine (Baltimore). 2023, 102:e33672. 10.1097\/MD.0000000000033672","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000511924","article-title":"Breast disorders in adolescence: a review of the literature","volume":"16","author":"Mareti E","year":"2021","unstructured":"Mareti E, Vatopoulou A, Spyropoulou GA, et al.. Breast disorders in adolescence: a review of the literature. Breast Care (Basel). 2021, 16:149-55. 10.1159\/000511924","journal-title":"Breast Care (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-3001","article-title":"Breast cancer immunotherapy: facts and hopes","volume":"24","author":"Emens LA","year":"2018","unstructured":"Emens LA. Breast cancer immunotherapy: facts and hopes. Clin Cancer Res. 2018, 24:511-20. 10.1158\/1078-0432.CCR-16-3001","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02736-z","article-title":"Pembrolizumab and atezolizumab in triple-negative breast cancer","volume":"70","author":"Kwapisz D","year":"2021","unstructured":"Kwapisz D. Pembrolizumab and atezolizumab in triple-negative breast cancer. Cancer Immunol Immunother. 2021, 70:607-17. 10.1007\/s00262-020-02736-z","journal-title":"Cancer Immunol Immunother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.8931","article-title":"Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib KEYNOTE-012 study","volume":"34","author":"Nanda R","year":"2016","unstructured":"Nanda R, Chow LQ, Dees EC, et al.. Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib KEYNOTE-012 study. J Clin Oncol. 2016, 34:2460-7. 10.1200\/JCO.2015.64.8931","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000464353","article-title":"PD-1\/PD-L1 pathway in breast cancer","volume":"40","author":"Sch\u00fctz F","year":"2017","unstructured":"Sch\u00fctz F, Stefanovic S, Mayer L, von Au A, Domschke C, Sohn C. PD-1\/PD-L1 pathway in breast cancer. Oncol Res Treat. 2017, 40:294-7. 10.1159\/000464353","journal-title":"Oncol Res Treat"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30445-9","article-title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","volume":"21","author":"Marabelle A","year":"2020","unstructured":"Marabelle A, Fakih M, Lopez J, et al.. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol. 2020, 21:1353-65. 10.1016\/S1470-2045(20)30445-9","journal-title":"Lancet Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid P","year":"2020","unstructured":"Schmid P, Cortes J, Pusztai L, et al.. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020, 382:810-21. 10.1056\/NEJMoa1910549","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147517","article-title":"Immunotherapy in breast cancer","volume":"25","author":"Dvir K","year":"2024","unstructured":"Dvir K, Giordano S, Leone JP. Immunotherapy in breast cancer. Int J Mol Sci. 2024, 25:7517. 10.3390\/ijms25147517","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32531-9","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","volume":"396","author":"Cortes J","year":"2020","unstructured":"Cortes J, Cescon DW, Rugo HS, et al.. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial. Lancet. 2020, 396:1817-28. 10.1016\/S0140-6736(20)32531-9","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2022.05.006","article-title":"Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: current status in clinical trials","volume":"10","author":"Song Y","year":"2023","unstructured":"Song Y, Bi Z, Liu Y, Qin F, Wei Y, Wei X. Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: current status in clinical trials. Genes Dis. 2023, 10:76-88. 10.1016\/j.gendis.2022.05.006","journal-title":"Genes Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25769","article-title":"Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers","volume":"9","author":"Chan GH","year":"2018","unstructured":"Chan GH, Ong PY, Low JJ, et al.. Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers. Oncotarget. 2018, 9:30649-60. 10.18632\/oncotarget.25769","journal-title":"Oncotarget"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001","article-title":"First-line genomic profiling in previously untreated advanced solid tumors for identification of targeted therapy opportunities","volume":"6","author":"Matsubara J","year":"2023","unstructured":"Matsubara J, Mukai K, Kondo T, et al.. First-line genomic profiling in previously untreated advanced solid tumors for identification of targeted therapy opportunities. JAMA Netw Open. 2023, 6:e2323336. 10.1001","journal-title":"JAMA Netw Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/361042-immunotherapy-based-combination-therapy-for-the-successful-treatment-of-coexisting-primary-and-axillary-accessory-breast-cancers-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:57:49Z","timestamp":1746187069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/361042-immunotherapy-based-combination-therapy-for-the-successful-treatment-of-coexisting-primary-and-axillary-accessory-breast-cancers-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.83340","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}